§ BIOTECHNOLOGY
USD · Biotechnology

RYTM

RHYTHM PHARMACEUTICALS INC
USDSector · BiotechnologyBeta · 2.05
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
178 increased/new, 103 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B26.45EPS (TTM)-3.03
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
RA CAPITAL MANAGEMENT, L.P.6.7M6.1%±0%
BlackRock, Inc.6.2M0.0%−1%
BAKER BROS. ADVISORS LP5.6M2.8%±0%
PRIMECAP MANAGEMENT CO/CA/3.4M0.2%−2%
VANGUARD PORTFOLIO MANAGEMENT LLC3.0Mn/an/a
VANGUARD CAPITAL MANAGEMENT LLC3.0Mn/an/a
◇ AC INTELLIGENCE

Top institutional owners for RYTM as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER98.7% · 0 holders
OTHER0.8% · 194 holders
QUALITY / COMPOUNDER0.2% · 26 holders
PASSIVE / INDEX0.1% · 10 holders
DEALER / BANK0.1% · 28 holders
TACTICAL / MACRO0.0% · 5 holders
SYSTEMATIC / QUANT0.0% · 8 holders
INCOME / DEFENSIVE0.0% · 15 holders
GROWTH / MOMENTUM0.0% · 1 holder
ACTIVIST0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for RYTM in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention RYTM yet.